Literature DB >> 18192106

Risk factors of venous thromboembolism in thai patients.

Pantep Angchaisuksiri1, Vichai Atichartakarn, Katcharin Aryurachai, Napaporn Archararit, Buppa Rachakom, Kanlayanee Atamasirikul, Arjit Tiraganjana.   

Abstract

Venous thromboembolism (VTE) has been reported to be less common among Thais than Caucasians. Whether this observation reflects genetic or environmental factors, or both, is uncertain. To identify genetic and acquired risk factors of Thai patients with VTE, we enrolled in the study 105 consecutive Thai patients (34 men, 71 women) who had an objectively confirmed history of VTE. A complete clinical summary was obtained from each patient, with emphasis on personal and family history of VTE, as well as circumstantial vascular risk factors (surgery, immobilization, pregnancy, postpartum condition, trauma, oral contraceptive use, and malignancy). Of the 105 patients, 19% were found to have a malignancy. The mean age at the time of the first thrombotic episode was 52.1 years (range, 29-76 years), compared with 42.6 years (range, 17-82 years) for the patients without malignancy. Of the 85 patients without malignancy, 12.3% had protein S deficiency, 8.9% had protein C deficiency, 4.7% had antithrombin deficiency, 10.4% had antiphospholipid antibody, 30.4% had an elevated factor VIII level, 26.8% had an elevated factor XI level, 5.3% had hyperhomocysteinemia, and 16.5% were on oral contraceptives before the thrombotic episode. Factor V Leiden, the G20210A prothrombin gene mutation, and homozygosity for the C677T methylenetetrahydrofolate reductase (MTHFR) gene variant were not found. The VTE in 7.1% of the patients was considered to be secondary to recent surgery, trauma, and/or immobilization. Compared with studies of Caucasian patients, there were significant differences in the risk factors for VTE, with protein S deficiency and protein C deficiency being more common in the Thai patients. In contrast, factor V Leiden, the G20210A prothrombin gene mutation, and the C677T MTHFR gene mutation are not genetic risk factors among Thai patients with VTE. Malignancy and the use of oral contraceptives were the most common acquired risk factors for VTE in the Thai patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18192106     DOI: 10.1007/bf02983995

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  46 in total

1.  Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population.

Authors:  P Angchaisuksiri; S Pingsuthiwong; K Aryuchai; M Busabaratana; T Sura; V Atichartakarn; P Sritara
Journal:  Am J Hematol       Date:  2000-10       Impact factor: 10.047

2.  Homozygous protein S deficiency in an infant with purpura fulminans.

Authors:  C Mahasandana; V Suvatte; A Chuansumrit; R A Marlar; M J Manco-Johnson; L J Jacobson; W E Hathaway
Journal:  J Pediatr       Date:  1990-11       Impact factor: 4.406

3.  Prevalence of factor V Leiden in the Chinese population.

Authors:  C H Ho; W K Chau; H C Hsu; J P Gau; C M Chih
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1999-12

4.  The mutation at position 20210 in the 3'-untranslated region of the prothrombin gene is extremely rare in Taiwanese Chinese patients with venous thrombophilia.

Authors:  J S Lin; M C Shen; W Tsay
Journal:  Thromb Haemost       Date:  1998-08       Impact factor: 5.249

5.  [Factor V Leiden and PTG20210A gene mutation in patients with venous thrombosis and healthy blood donors].

Authors:  C Bai; J Pan; X Li
Journal:  Zhonghua Yi Xue Za Zhi       Date:  1999-12

6.  The incidence of postoperative deep vein thrombosis in Thais.

Authors:  P Phornphibulaya; P Buranapong; N Ruksawin; J Viranuvatti
Journal:  J Med Assoc Thai       Date:  1984-07

7.  Deep venous thrombosis in Taiwan.

Authors:  H C Lee; W B Liao; M J Bullard; T S Hsu
Journal:  Jpn Heart J       Date:  1996-11

8.  An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study.

Authors:  M M Samama
Journal:  Arch Intern Med       Date:  2000 Dec 11-25

9.  Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population.

Authors:  Yanhui Lu; Yanfen Zhao; Guozhang Liu; Xiaoling Wang; Zhihong Liu; Baiping Chen; Rutai Hui
Journal:  Thromb Res       Date:  2002-04-01       Impact factor: 3.944

10.  World distribution of factor V Leiden.

Authors:  D C Rees; M Cox; J B Clegg
Journal:  Lancet       Date:  1995-10-28       Impact factor: 79.321

View more
  16 in total

1.  Prognostic role of D-dimer in patients with lung cancer: a meta-analysis.

Authors:  Xuelei Ma; Yanyan Li; Jing Zhang; Jingwen Huang; Lei Liu
Journal:  Tumour Biol       Date:  2013-10-10

2.  High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites.

Authors:  Amanda B Payne; Connie H Miller; W Craig Hooper; Cathy Lally; Harland D Austin
Journal:  Ethn Dis       Date:  2014       Impact factor: 1.847

Review 3.  Dysfunction of protein C anticoagulant system, main genetic risk factor for venous thromboembolism in northeast Asians.

Authors:  Tong Yin; Toshiyuki Miyata
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

Review 4.  The role of ethnicity, age and gender in venous thromboembolism.

Authors:  Martina Montagnana; Emmanuel J Favaloro; Massimo Franchini; Gian Cesare Guidi; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

5.  High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the Southeast Asian patients with portal vein thrombosis.

Authors:  Korn Lertpipopmetha; Chirayu U Auewarakul
Journal:  BMC Gastroenterol       Date:  2011-06-10       Impact factor: 3.067

6.  Hereditary thrombophilia in Korean patients with idiopathic pulmonary embolism.

Authors:  Mirae Lee; Hye Jin No; Shin Yi Jang; Nari Kim; Seung Hyuk Choi; Hojoong Kim; Sun-Hee Kim; Hee-Jin Kim; Duk-Kyung Kim
Journal:  Yonsei Med J       Date:  2012-05       Impact factor: 2.759

7.  Long-Term Effects of Unprovoked Venous Thromboembolism on Mortality and Major Cardiovascular Events.

Authors:  Wei-Ting Chang; Chia-Li Chang; Chung-Han Ho; Chon-Seng Hong; Jhi-Joung Wang; Zhih-Cherng Chen
Journal:  J Am Heart Assoc       Date:  2017-05-03       Impact factor: 5.501

8.  Recurrent mutations in a SERPINC1 hotspot associate with venous thrombosis without apparent antithrombin deficiency.

Authors:  Wei Zeng; Bei Hu; Liang Tang; Yan-Yan You; Mara Toderici; Maria Eugenia de la Morena-Barrio; Javier Corral; Yu Hu
Journal:  Oncotarget       Date:  2017-09-28

9.  Epidemiology of Cancer-Associated Thrombosis in Asia: A Systematic Review.

Authors:  Lai Heng Lee; Chandramouli Nagarajan; Chuen Wen Tan; Heng Joo Ng
Journal:  Front Cardiovasc Med       Date:  2021-05-21

10.  Prevalence and Risk Factors for Complications in Patients with Nontransfusion Dependent Alpha- and Beta-Thalassemia.

Authors:  Poramed Winichakoon; Adisak Tantiworawit; Thanawat Rattanathammethee; Sasinee Hantrakool; Chatree Chai-Adisaksopha; Ekarat Rattarittamrong; Lalita Norasetthada; Pimlak Charoenkwan
Journal:  Anemia       Date:  2015-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.